Business Description
Lin BioScience Inc
ISIN : TW0006696008
Share Class Description:
ROCO:6696: Ordinary SharesTotal Employee Number:
15Description
Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 714.18 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -70.2 | |||||
3-Year EPS without NRI Growth Rate | -56.4 | |||||
3-Year FCF Growth Rate | -49.3 | |||||
3-Year Book Growth Rate | 98 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 68.5 | |||||
9-Day RSI | 73.92 | |||||
14-Day RSI | 74.99 | |||||
3-1 Month Momentum % | -8.58 | |||||
6-1 Month Momentum % | 5.07 | |||||
12-1 Month Momentum % | 175.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 58.18 | |||||
Quick Ratio | 58.18 | |||||
Cash Ratio | 57.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | -1.45 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -24.89 | |||||
ROA % | -11.22 | |||||
ROIC % | -89.61 | |||||
3-Year ROIIC % | -26.93 | |||||
ROC (Joel Greenblatt) % | -5888.28 | |||||
ROCE % | -22.04 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 5.38 | |||||
Price-to-Tangible-Book | 5.44 | |||||
EV-to-EBIT | -21.26 | |||||
EV-to-EBITDA | -21.44 | |||||
EV-to-FCF | -34.23 | |||||
Price-to-Projected-FCF | 24.04 | |||||
| Price-to-Net-Current-Asset-Value | 32.8 | |||||
| Price-to-Net-Cash | 36.15 | |||||
Earnings Yield (Greenblatt) % | -4.71 | |||||
FCF Yield % | -2.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lin BioScience Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | |||
| EPS (TTM) (NT$) | -16.6 | ||
| Beta | 0.0938 | ||
| 3-Year Sharpe Ratio | 0.8 | ||
| 3-Year Sortino Ratio | 2.74 | ||
| Volatility % | 91.95 | ||
| 14-Day RSI | 74.99 | ||
| 14-Day ATR (NT$) | 46.784826 | ||
| 20-Day SMA (NT$) | 522.275 | ||
| 12-1 Month Momentum % | 175.52 | ||
| 52-Week Range (NT$) | 143 - 760 | ||
| Shares Outstanding (Mil) | 82.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lin BioScience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lin BioScience Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lin BioScience Inc Frequently Asked Questions
What is Lin BioScience Inc(ROCO:6696)'s stock price today?
The current price of ROCO:6696 is NT$698.00. The 52 week high of ROCO:6696 is NT$760.00 and 52 week low is NT$143.00.
When is next earnings date of Lin BioScience Inc(ROCO:6696)?
The next earnings date of Lin BioScience Inc(ROCO:6696) is .
Does Lin BioScience Inc(ROCO:6696) pay dividends? If so, how much?
Lin BioScience Inc(ROCO:6696) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Lin BioScience Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers